Niemczuk P, Perkins R M, Talbot I C, Critchley D R
Br J Cancer. 1982 Apr;45(4):500-5. doi: 10.1038/bjc.1982.85.
In a retrospective study we have used an immunoperoxidase procedure to localize the glycoprotein fibronectin in human rectal carcinomas, concentrating on tumour invading thick-walled extramural veins. Fibronectin was present in 29 out of 38 cases, in connective tissue stroma, and was not in direct association with the tumour cells, except in areas of necrosis. We found no correlation between the presence or absence of stromal fibronectin and (1) the degree of cellular differentiation within the tumour, (2) tumour progression (Dukes' classification) (3) the subsequent development of metastases and (4) patient longevity. OUr results do not support the conclusions from in vitro studies (Smith et al., 1979) that the metastatic potential of carcinomas may be partly determined by the ability of tumour cells to synthesize pericellular fibronectin.
在一项回顾性研究中,我们采用免疫过氧化物酶法对人直肠癌中的糖蛋白纤连蛋白进行定位,重点研究肿瘤侵袭的厚壁壁外静脉。38例中有29例在结缔组织基质中存在纤连蛋白,除坏死区域外,纤连蛋白与肿瘤细胞无直接关联。我们发现基质纤连蛋白的有无与以下方面均无相关性:(1)肿瘤内细胞分化程度;(2)肿瘤进展(杜克分类法);(3)随后转移的发生;(4)患者生存期。我们的结果不支持体外研究(史密斯等人,1979年)得出的结论,即癌的转移潜能可能部分取决于肿瘤细胞合成细胞周围纤连蛋白的能力。